The global breast imaging technologies market was valued at USD 5.2 billion in 2021 and is expected to exceed USD 9.5 billion by 2027,anticipated to expand at a CAGR of 6.90 % from 2022 to 2027.
Breast imaging is a type of medical technology used to detect or diagnose breast cancer in females. Breast imaging medical technology facilitates in the diagnosis of many breast-related disorders by providing radiological images of women's breasts.Breast imaging technology includes nuclear imaging, mammography, breast ultrasonography, and magnetic resonance imaging (MRI).The primary goal of this test is to detect breast cancer and other breast-related disorders as early as possible, while they are still treatable.Breast imaging aids in the diagnosis of breast cancer and other related problems, so the market is expected to grow rapidly as the number of breast cancer cases increases.
Furthermore, the increasing number of government initiatives to sprea awareness about the importance of early detection of breast cancer will be a major driver of the growth rate of the breast imaging market. Another important factor driving market growth is technological advancement in breast imaging modalities. And in addition to, the increasing geriatric population, as well as an increase in public-private investments, grants, and funding, will be major drivers of market growth and the increase in the number of R&D activities will provide beneficial opportunities for the growth of the breast imaging technologies market.Along with this increase in technological development in the field of medical devices, the breast imaging market's growth rate will be further expanded in the future.
On the other hand, the high cost of imaging systems or technology will stymie market growth.In addition, the unfavourable reimbursement scenario in developing and underdeveloped economies will be a significant challenge for the breast imaging market.However, strict regulatory approval processes and the emergence of unfavourable conditions as a result of the COVID-19 outbreak will act as a restraint and impede the market's growth rate during the forecast period of 2022-2029.
Forecast Period 2022 to 2027
CAGR of 6.90 % during the review period (2022 to 2027).
By End User
2017 to 2021
2022 to 2029
Number of Pages
Yes, the report can be customized as per your needs
By Technology, it is segmented into
By End User, it is segmented into
North America dominates the breast imaging technologies market because of the growing adoption of advanced healthcare imaging technolog. Additionally, the increasing prevalence of breast cancer will further enhance the market's growth rate in this region. Due to the region's growing patient pool, Asia-Pacific is expected to grow during the forecast period. Furthermore, an ageing population and rising levels of personal disposable income will drive the market's growth rate in this region.The country section of the report also includes individual market impacting factors as well as changes in regulation in the domestic market that affect current and future market trends. Data points such as downstream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the indicators used to forecast the market scenario for individual countries. The countries covered in The breast imaging technologies market report are:
o North America
o Rest of the World
The major players of breast imaging technologies market are Koninklijke Philips, Hitachi Ltd., Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, General Electric, Aspect Imaging Ltd (Israel), Bruker, Aurora Health Care, FONAR Corp., ESAOTE SPA, TOSHIBA CORPORATION, Neusoft Corporation, Sanrad Medical Systems Private Limited, FUJIFILM Holdings Corporation, ONEX Corporation, Hologic, Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Imaging Diagnostic Systems Inc., Agfa-Gevaert Group, and Koning Health.
What is the current Market size and compound annual growth rate (CAGR) of the Breast Imaging Technologies during the forecast period (2022-2027)?
The Breast Imaging Technologies Market is growing at a CAGR of 6.90 % over the next 5 years.
Who are the key players in Breast Imaging Technologies Market?
The key players of Breast Imaging Technologies Market are Hologic, Inc., GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Canon Inc., Aurora Healthcare US Corp., Allengers, Dilon Technologies, Inc., Planmed Oy, Delphinus Medical Technologies, Inc., Micrima Limited, CMR Naviscan Corporation, SuperSonic Imagine, and Carestream Health.
What region does this Breast Imaging Technologies Market report covers?
North America (the United States, Canada, and Mexico), Europe (Germany, France, UK, Russia, and
Italy), Asia-Pacific (China, Japan, Korea, India, and Southeast Asia), South America (Brazil, Argentina,
Colombia, etc.), The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
All our reports are custom made to your company needs to a certain extent, we do provide 5 free
consulting hours along with purchase of each report, and this will allow you to request any additional
data to customize the report as your needs.
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.